Visitors Now:
Total Visits:
Total Stories:
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Cellect Biotechnology shares skyrocket as first blood cancer patient treated in clinical trial

Wednesday, February 8, 2017 8:33
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Shares in Cellect Biotechnology Ltd (NASDAQ: APOP) soared almost 50% higher in New York as it told investors it had treated the first blood cancer patient in its recently started phase I/II trial of its stem cell technology ApoGraft.

The firm’s technology means it can select stem cells from any given tissue for any clinical indication.

This trial in Israel is intended to assess the Cellect ApoGraft process which is designed to prevent Graft-versus-Host Disease (GvHD) -  a common complication associated with stem cell transplant in which the transplanted immune cells attack the recipient’s cells.

It will test stem cells transplanted from a matched donor related to the patient.

GvHD is a life-threatening condition occurring in up to 50% of stem cell transplants.

Cellect chief executive Shai Yarkoni said: “Enrolling our first cancer patient to be treated using our groundbreaking method is a critical milestone for millions of patients worldwide.

“ApoGraft has been proven to be effective in assisting successful stem cells transplants and preventing GvHD during our animal studies.  I am excited with prospects of Cellect becoming a key contributor to the fast-growing market for stem cells based products enabling 21st century regenerative medicine.”

Story by ProactiveInvestors



Source: http://www.proactiveinvestors.com/companies/news/172869/cellect-biotechnology-shares-skyrocket-as-first-blood-cancer-patient-treated-in-clinical-trial-172869.html

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.